Works matching IS 13524585 AND DT 2022 AND VI 28 AND IP 1

Results: 19

Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 16, doi. 10.1177/13524585211059766

By:

Thompson, Alan J;
Carroll, William;
Ciccarelli, Olga;
Comi, Giancarlo;
Cross, Anne;
Donnelly, Alexis;
Feinstein, Anthony;
Fox, Robert J;
Helme, Anne;
Hohlfeld, Reinhard;
Hyde, Robert;
Kanellis, Pamela;
Landsman, Douglas;
Lubetzki, Catherine;
Marrie, Ruth Ann;
Morahan, Julia;
Montalban, Xavier;
Musch, Bruno;
Rawlings, Sarah;
Salvetti, Marco

Publication type:

Article

Administrative data for observational research in multiple sclerosis: Opportunities and challenges.

Published in:

2022

By:

Marrie, Ruth Ann;
McKay, Kyla

Publication type:

Editorial

Depression readmission risk is elevated in multiple sclerosis compared to other chronic illnesses.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 139, doi. 10.1177/13524585211051316

By:

Schorr, Emily M;
Kurz, Daniel;
Rossi, Kyle C;
Zhang, Margaret;
Yeshokumar, Anusha K;
Jette, Nathalie;
Dhamoon, Mandip S

Publication type:

Article

Aquaporin-4 antibody neuromyelitis optica spectrum disorder: A paraneoplastic disease?

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 163, doi. 10.1177/13524585211039755

By:

Abdel-Mannan, Omar;
Hacohen, Yael

Publication type:

Article

SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action?

Published in:

2022

By:

Rommer, Paulus S;
Bsteh, Gabriel;
Berger, Thomas;
Zettl, Uwe Klaus

Publication type:

Letter

Pediatric paraneoplastic neuromyelitis optica spectrum disorder associated with ovarian teratoma.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 160, doi. 10.1177/13524585211037582

By:

Tardo, Lauren;
Wang, Cynthia;
Rajaram, Veena;
Greenberg, Benjamin M

Publication type:

Article

Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 154, doi. 10.1177/13524585211019650

By:

Cortese, Rosa;
Battaglini, Marco;
Parodi, Francesca;
Stromillo, Maria Laura;
Portaccio, Emilio;
Razzolini, Lorenzo;
Giorgio, Antonio;
Sormani, Maria Pia;
Amato, Maria Pia;
De Stefano, Nicola

Publication type:

Article

Optic chiasm involvement in AQP-4 antibody–positive NMO and MOG antibody–associated disorder.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 149, doi. 10.1177/13524585211011450

By:

Tajfirouz, Deena;
Padungkiatsagul, Tanyatuth;
Beres, Shannon;
Moss, Heather E;
Pittock, Sean;
Flanagan, Eoin;
Kunchok, Amy;
Shah, Shailee;
Bhatti, M Tariq;
Chen, John J

Publication type:

Article

Effect of continuous positive airway pressure treatment of obstructive sleep apnea-hypopnea in multiple sclerosis: A randomized, double-blind, placebo-controlled trial (SAMS-PAP study).

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 82, doi. 10.1177/13524585211010390

By:

Khadadah, Sulaiman;
Kimoff, R John;
Duquette, Pierre;
Jobin, Vincent;
Lapierre, Yves;
Benedetti, Andrea;
Johara, Fatema T;
Robinson, Ann;
Roger, Elaine;
Bar-Or, Amit;
Leonard, Gabriel;
Kaminska, Marta;
Trojan, Daria A

Publication type:

Article

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 102, doi. 10.1177/13524585211010097

By:

van Lierop, Zoë YGJ;
Wieske, Luuk;
Koel-Simmelink, Marleen JA;
Chatterjee, Madhurima;
Dekker, Iris;
Leurs, Cyra E;
Willemse, Eline AJ;
Moraal, Bastiaan;
Barkhof, Frederik;
Eftimov, Filip;
Uitdehaag, Bernhard MJ;
Killestein, Joep;
Teunissen, Charlotte E

Publication type:

Article

CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 71, doi. 10.1177/13524585211010082

By:

Comabella, Manuel;
Clarke, Margareta A;
Schaedelin, Sabine;
Tintoré, Mar;
Pareto, Deborah;
Fissolo, Nicolás;
Pinteac, Rucsanda;
Granziera, Cristina;
Sastre-Garriga, Jaume;
Benkert, Pascal;
Auger, Cristina;
Kuhle, Jens;
Montalban, Xavier;
Rovira, Alex

Publication type:

Article

Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 111, doi. 10.1177/13524585211010294

By:

De Stefano, Nicola;
Sormani, Maria Pia;
Giovannoni, Gavin;
Rammohan, Kottil;
Leist, Thomas;
Coyle, Patricia K;
Dangond, Fernando;
Keller, Birgit;
Alexandri, Nektaria;
Galazka, Andrew

Publication type:

Article

Disability in multiple sclerosis is related to thalamic connectivity and cortical network atrophy.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 61, doi. 10.1177/13524585211008743

By:

Schoonheim, Menno M;
Pinter, Daniela;
Prouskas, Stefanos E;
Broeders, Tommy AA;
Pirpamer, Lukas;
Khalil, Michael;
Ropele, Stefan;
Uitdehaag, Bernard MJ;
Barkhof, Frederik;
Enzinger, Christian;
Geurts, Jeroen JG

Publication type:

Article

Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: A systematic review.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 29, doi. 10.1177/13524585211008760

By:

Allanach, Jessica R;
Farrell III, John W.;
Mésidor, Miceline;
Karimi-Abdolrezaee, Soheila

Publication type:

Article

Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 49, doi. 10.1177/13524585211007086

By:

Ciotti, John R;
Eby, Noah S;
Brier, Matthew R;
Wu, Gregory F;
Chahin, Salim;
Cross, Anne H;
Naismith, Robert T

Publication type:

Article

Aging with multiple sclerosis: A longitudinal study of physical function, mental health, and memory in two cohorts of US women.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 121, doi. 10.1177/13524585211007739

By:

Cortese, Marianna;
Bjornevik, Kjetil;
Chitnis, Tanuja;
Ascherio, Alberto;
Munger, Kassandra L

Publication type:

Article

Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 93, doi. 10.1177/13524585211005657

By:

Signoriello, Elisabetta;
Lus, Giacomo;
Bonavita, Simona;
Lanzillo, Roberta;
Saccà, Francesco;
Landi, Doriana;
Frau, Jessica;
Baroncini, Damiano;
Zaffaroni, Mauro;
Maniscalco, Giorgia Teresa;
Curti, Erica;
Sartori, Arianna;
Cepparulo, Simone;
Marfia, Girolama Alessandra;
Nicoletti, Carolina Gabri;
Carotenuto, Antonio;
Nociti, Viviana;
Caleri, Francesca;
Sormani, Maria Pia;
Signori, Alessio

Publication type:

Article

Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 132, doi. 10.1177/13524585211005339

By:

Portaccio, Emilio;
Fonderico, Mattia;
Hemmer, Bernhard;
Derfuss, Tobias;
Stankoff, Bruno;
Selmaj, Krzysztof;
Tintorè, Mar;
Amato, Maria Pia

Publication type:

Article

Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 7, doi. 10.1177/1352458520949158

By:

Jordan, Allison LM;
Yang, Jennifer;
Fisher, Caitlyn J;
Racke, Michael K;
Mao-Draayer, Yang

Publication type:

Article